ChemImpex Anisomycin (from Streptomyces griseolus); 98% (AT,HPLC); 22862-76-6; MFCD00077650, 250MG

Anisomycin, derived from the bacterium Streptomyces griseolus, is a potent antibiotic and a valuable tool in biochemical research. This compound is recognized for its ability to inhibit protein synthesis, making it an essential reagent in studies related to cellular processes, gene expression, and the mechanisms of action of various drugs. Anisomycin has been widely utilized in the fields of molecular biology and pharmacology, particularly in experiments involving apoptosis and stress response pathways. Its unique structure, featuring a pyrrolidine ring and a methoxyphenyl group, contributes to its effectiveness in modulating cellular functions, providing researchers with a reliable means to explore complex biological systems.

In addition to its research applications, Anisomycin has shown promise in therapeutic contexts, particularly in cancer research, where it is being investigated for its potential to induce apoptosis in cancer cells. Its ability to selectively target protein synthesis pathways offers a strategic advantage over other compounds, allowing for more precise manipulation of cellular responses. With its multifaceted applications and ongoing research into its therapeutic potential, Anisomycin stands out as a crucial compound for professionals seeking to advance their understanding of cellular biology and develop innovative treatments.

Specifications

Safety & Regulations